NADPH oxidases-associated transition from Barrett's esophagus to adenocarcinoma

NADPH 氧化酶相关的巴雷特食管向腺癌的转变

基本信息

  • 批准号:
    7229819
  • 负责人:
  • 金额:
    $ 21.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-05-01 至 2009-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Gastroesophageal reflux disease (GERD) affects more than 1 in 10 adults over 40 years of age and 1 in 4 adults over 60. Approximately 10% of GERD patients develop Barrett's esophagus (BE) where esophageal squamous epithelium damaged by reflux esophagitis is replaced by a metaplastic, intestinal- type epithelium. The specialized intestinal metaplasia of BE is associated with nearly a 30-125-fold increased risk for the development of esophageal adenocarcinoma. However, the mechanisms of progression from Barrett's esophagus (intestinal metaplasia) to dysplasia and to adenocarcinoma are not known. We propose that reactive oxygen species (ROS), which are elevated in BE and in adenocarcinoma, play a key role in the progression from BE to adenocarcinoma. Preliminary data demonstrate that the NADPH oxidase isoform NOX5 is overexpressed in an adenocarcinoma cell line (SEG1) where it may overproduce ROS. We will therefore test the central hypothesis that acid exposure upregulates NADPH oxidases in Barrett's intestinal metaplastic cells, causing production of free radicals, which in turn may upregulate cyclooxygenase 2 (COX-2) and cyclin D1. Upregulation of COX-2 and cyclin-D1 will increase cell proliferation and decrease apoptosis in these metaplastic cells. Persistent acid reflux present in BE patients may cause continuous changes including high levels of ROS, increased cell proliferation and decreased apoptosis, which may lead to DNA damage and increased mutations contributing to the progression from metaplasia to dysplasia and to esophageal adenocarcinoma. To test this hypothesis we will: 1) Examine whether NADPH oxidases, in particular NOX5, are upregulated by acid exposure in Barrett's metaplastic cells and SEG1 cells; 2) Examine whether calcium and cyclic AMP response element binding protein (CREB) mediates acid-induced expression of NADPH oxidases (in particular NOX5) in a Barrett's cell line and in SEG1 cells; 3) Define the role of NADPH oxidases-generated ROS in upregulating COX-2 and cyclin-D1. A better understanding of the signal transduction pathway of acid induced upregulation of NADPH oxidases, in particular NOX5, leading to increased cell proliferation and decreased apoptosis, may provide a rational approach to the prevention of development of esophageal adenocarcinoma.
描述(由申请人提供):胃食管反流病(GERD)影响超过1/10的40岁以上成人和1/4的60岁以上成人。大约10%的GERD患者发展为巴雷特食管(BE),其中由反流性食管炎损伤的食管鳞状上皮被化生的肠型上皮替代。BE的特化肠上皮化生与食管腺癌发生的风险增加近30-125倍相关。然而,从巴雷特食管(肠化生)发展到异型增生和腺癌的机制尚不清楚。我们认为,活性氧(ROS),这是升高BE和腺癌,发挥了关键作用,从BE到腺癌的进展。初步数据表明,NADPH氧化酶亚型NOX 5在腺癌细胞系(SEG 1)中过表达,可能会过度产生ROS。因此,我们将测试的核心假设,酸暴露上调NADPH氧化酶在巴雷特肠化生细胞,导致产生的自由基,这反过来可能上调环氧合酶2(考克斯-2)和细胞周期蛋白D1。上调考克斯-2和cyclin-D1将增加这些化生细胞的细胞增殖和减少凋亡。BE患者中存在的持续性酸反流可能导致持续变化,包括高水平的ROS、细胞增殖增加和细胞凋亡减少,这可能导致DNA损伤和突变增加,从而导致从化生到异型增生和食管腺癌的进展。为了验证这一假设,我们将:1)检查NADPH氧化酶,特别是NOX 5,是否被巴雷特化生细胞和SEG 1细胞中的酸暴露上调; 2)检查钙和环AMP反应元件结合蛋白(CREB)是否介导酸诱导的NADPH氧化酶表达。(特别是NOX 5); 3)确定NADPH氧化酶产生的ROS在上调考克斯-2和细胞周期蛋白-D1中的作用。更好地了解酸诱导的NADPH氧化酶,特别是NOX 5上调,导致细胞增殖增加和凋亡减少的信号转导途径,可能提供一个合理的方法来预防食管腺癌的发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WEIBIAO CAO其他文献

WEIBIAO CAO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WEIBIAO CAO', 18)}}的其他基金

NADPH oxidase-associated transition from Barrett's esophagus to adenocarcinoma
NADPH 氧化酶相关的巴雷特食管向腺癌的转变
  • 批准号:
    7765562
  • 财政年份:
    2009
  • 资助金额:
    $ 21.85万
  • 项目类别:
NADPH oxidase-associated transition from Barrett's esophagus to adenocarcinoma
NADPH 氧化酶相关的巴雷特食管向腺癌的转变
  • 批准号:
    8068799
  • 财政年份:
    2009
  • 资助金额:
    $ 21.85万
  • 项目类别:
COBRE: RIH: THEME B: PATHOGENESIS OF GI TUMORS, GERD, ESOPHAGITIS, SUBTITLE:
COBRE:RIH:主题 B:胃肠道肿瘤、胃食管反流病、食管炎的发病机制,副标题:
  • 批准号:
    7960509
  • 财政年份:
    2009
  • 资助金额:
    $ 21.85万
  • 项目类别:
NADPH oxidase-associated transition from Barrett's esophagus to adenocarcinoma
NADPH 氧化酶相关的巴雷特食管向腺癌的转变
  • 批准号:
    8461663
  • 财政年份:
    2009
  • 资助金额:
    $ 21.85万
  • 项目类别:
NADPH oxidase-associated transition from Barrett's esophagus to adenocarcinoma
NADPH 氧化酶相关的巴雷特食管向腺癌的转变
  • 批准号:
    7578120
  • 财政年份:
    2009
  • 资助金额:
    $ 21.85万
  • 项目类别:
NADPH oxidase-associated transition from Barrett's esophagus to adenocarcinoma
NADPH 氧化酶相关的巴雷特食管向腺癌的转变
  • 批准号:
    8278044
  • 财政年份:
    2009
  • 资助金额:
    $ 21.85万
  • 项目类别:
NADPH oxidases-associated transition from Barrett's esophagus to adenocarcinoma
NADPH 氧化酶相关的巴雷特食管向腺癌的转变
  • 批准号:
    7013516
  • 财政年份:
    2006
  • 资助金额:
    $ 21.85万
  • 项目类别:
COBRE: RIH: THEME B: PATHOGENESIS OF GI TUMORS, GERD, ESOPHAGITIS, SUBTITLE:
COBRE:RIH:主题 B:胃肠道肿瘤、胃食管反流病、食管炎的发病机制,副标题:
  • 批准号:
    7381875
  • 财政年份:
    2006
  • 资助金额:
    $ 21.85万
  • 项目类别:
COBRE: RIH: THEME B: PATHOGENESIS OF GI TUMORS, GERD, ESOPHAGITIS, SUBTITLE:
COBRE:RIH:主题 B:胃肠道肿瘤、胃食管反流病、食管炎的发病机制,副标题:
  • 批准号:
    7171101
  • 财政年份:
    2005
  • 资助金额:
    $ 21.85万
  • 项目类别:
COBRE: RIH: THEME B: PATHOGENESIS OF GI TUMORS, GERD, ESOPHAGITIS
COBRE:RIH:主题 B:胃肠道肿瘤、胃食管反流病、食管炎的发病机制
  • 批准号:
    6981778
  • 财政年份:
    2004
  • 资助金额:
    $ 21.85万
  • 项目类别:

相似国自然基金

大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
  • 批准号:
    30840003
  • 批准年份:
    2008
  • 资助金额:
    12.0 万元
  • 项目类别:
    专项基金项目

相似海外基金

Assessing The Impact of Heparanase and NDST2 Expression on Non-Small Cell Lung Adenocarcinoma Cell Motility
评估乙酰肝素酶和 NDST2 表达对非小细胞肺腺癌细胞运动的影响
  • 批准号:
    449570
  • 财政年份:
    2020
  • 资助金额:
    $ 21.85万
  • 项目类别:
    Studentship Programs
Analysis of cancer metastasis and invasion mechanism using a new lung adenocarcinoma cell line.
使用新的肺​​腺癌细胞系分析癌症转移和侵袭机制。
  • 批准号:
    16K10689
  • 财政年份:
    2016
  • 资助金额:
    $ 21.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Acquisition strategy of tumor-specific markers using established micropapillary pattern pulmonary adenocarcinoma cell line
使用已建立的微乳头模式肺腺癌细胞系获取肿瘤特异性标志物的策略
  • 批准号:
    26460441
  • 财政年份:
    2014
  • 资助金额:
    $ 21.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The antibetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo.
抗生素药物二甲双胍在体外和体内抑制食管腺癌细胞增殖。
  • 批准号:
    25860540
  • 财政年份:
    2013
  • 资助金额:
    $ 21.85万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The cell permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferations and can be used as the molecular targeting dru
细胞通透肽抑制胰腺导管腺癌细胞增殖,可作为分子靶向药物
  • 批准号:
    25461969
  • 财政年份:
    2013
  • 资助金额:
    $ 21.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic Research for elucidation of chemo-resistance in mucinous adenocarcinoma cell.
阐明粘液腺癌细胞化疗耐药性的基础研究。
  • 批准号:
    22791532
  • 财政年份:
    2010
  • 资助金额:
    $ 21.85万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
TAS::75 0849::TAS IN THIS PHASE I SBIR THE BREAST CANCER ADENOCARCINOMA CELL LI
TAS::75 0849::TAS 在这一阶段 I SBIR 乳腺癌腺癌细胞 LI
  • 批准号:
    8164743
  • 财政年份:
    2010
  • 资助金额:
    $ 21.85万
  • 项目类别:
Role of Endothelin-1 in osteoblastic bone metastasis produced by a human lung adenocarcinoma cell line
Endothelin-1 在人肺腺癌细胞系产生的成骨细胞骨转移中的作用
  • 批准号:
    19790127
  • 财政年份:
    2007
  • 资助金额:
    $ 21.85万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
CONNEXIN 43 EXPRESSION IN ADENOCARCINOMA CELL LINE
连接蛋白 43 在腺癌细胞系中的表达
  • 批准号:
    6972483
  • 财政年份:
    2004
  • 资助金额:
    $ 21.85万
  • 项目类别:
The mechanisms of highly metastetic capasity in highly metastatic subpopulations of lung adenocarcinoma cell line and these clinical applications
肺腺癌细胞系高转移亚群的高转移能力机制及临床应用
  • 批准号:
    15590831
  • 财政年份:
    2003
  • 资助金额:
    $ 21.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了